Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries G1 Therapeutics Inc (NQ: GTHX ) 7.150 UNCHANGED Last Price Updated: 4:00 PM EDT, Sep 17, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about G1 Therapeutics Inc < Previous 1 2 3 4 5 Next > Dow Tumbles Over 200 Points; CVS Health Cuts Profit Forecast August 07, 2024 Via Benzinga Topics Stocks Exposures US Equities Crude Oil Jumps Over 3%; Upstart Shares Spike Higher August 07, 2024 Via Benzinga Exposures Fossil Fuels Nasdaq Jumps 250 Points; Disney Earnings Beat Estimates August 07, 2024 Via Benzinga Topics Earnings Exposures Financial Why Is G1 Therapeutics (GTHX) Stock Up 66% Today? August 07, 2024 G1 Therapeutics stock is up on Wednesday following news that Pharmacosmos Group is acquiring GTHX for $7.15 per share. Via InvestorPlace Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday August 07, 2024 Pre-market stock movers are a hot topic on Wednesday and we have all of the latest news traders need to know about them this morning! Via InvestorPlace Analyst Ratings For G1 Therapeutics June 13, 2024 Via Benzinga Evaluating G1 Therapeutics: Insights From 5 Financial Analysts May 01, 2024 Via Benzinga Breaking Down G1 Therapeutics: 5 Analysts Share Their Views April 12, 2024 Via Benzinga G1 Therapeutics Stock: The Undervalued Gem Poised for a 30% Revenue Surge by 2025 July 15, 2024 While there’s no denying that G1 Therapeutics stock is highly speculative, investors should still check under the hood. Via InvestorPlace Biotech Bombshell: G1 Therapeutics Stock Is Too Much of a Gamble July 10, 2024 G1 Therapeutics stock is highly volatile, and investors should be wary now as G1 Therapeutics recently failed to achieve a clinical goal. Via InvestorPlace Ball To Rally More Than 23%? Here Are 10 Top Analyst Forecasts For Tuesday June 25, 2024 Via Benzinga Coffee Recall 2024: Over 250 Coffee Products Recalled Due to Botulism Fears June 24, 2024 A 2024 coffee recall is in effect for products made by Snapchill LLC due to concerns of botulism from the FDA for hundreds of canned coffees. Via InvestorPlace Exposures Product Safety Ginkgo Bioworks Layoffs 2024: What to Know About the Latest DNA Job Cuts June 24, 2024 Ginkgo Bioworks layoffs are a hot topic as the company prepares to cut 158 jobs this week with more headcount reductions coming next week. Via InvestorPlace Topics Workforce Exposures Layoff Forecasting The Future: 5 Analyst Projections For G1 Therapeutics February 28, 2024 Via Benzinga Alnylam's Closely Watched Phase 3 Heart Disease Trial Of Vutrisiran Hits Primary Endpoint, Shares Surge June 24, 2024 Alnylam Pharmaceuticals reports positive results from the HELIOS-B Phase 3 study of vutrisiran for ATTR amyloidosis with cardiomyopathy. The trial showed significant reductions in mortality and... Via Benzinga Why Is Cancer-Focused G1 Therapeutics Stock Trading Lower On Monday? June 24, 2024 Shares of G1 Therapeutics are down after release of Phase 3 trial results for trilaciclib in TNBC. Via Benzinga Why Is G1 Therapeutics (GTHX) Stock Down 56% Today? June 24, 2024 G1 Therapeutics stock is down on Monday as GTHX investors react to the company's Phase 3 clinical trial of trilaciclib failing. Via InvestorPlace Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday June 24, 2024 It's time to dive into the biggest pre-market stock movers as we check out all of the hottest news on Monday morning! Via InvestorPlace 10 Health Care Stocks With Whale Alerts In Today's Session June 11, 2024 Via Benzinga Why Applied DNA Sciences Shares Are Trading Lower By Around 68%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session May 28, 2024 Via Benzinga 12 Health Care Stocks Moving In Tuesday's Intraday Session May 28, 2024 Via Benzinga What's Going On With G1 Therapeutics Stock? May 09, 2024 According to a report, G1 Therapeutics has received and rejected multiple offers from TerSera Therapeutics. According to the report, one offer from TerSera is rumored to have a contingent value right... Via Benzinga 12 Health Care Stocks Moving In Thursday's Intraday Session May 09, 2024 Via Benzinga GTHX Stock Earnings: G1 Therapeutics Beats EPS, Misses Revenue for Q1 2024 May 01, 2024 GTHX stock results show that G1 Therapeutics beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. Via InvestorPlace 12 Health Care Stocks Moving In Monday's Pre-Market Session April 08, 2024 Via Benzinga 12 Health Care Stocks Moving In Wednesday's Intraday Session February 28, 2024 Via Benzinga Why Is Breast Cancer-Focused G1 Therapeutics Stock Trading Lower Today? February 13, 2024 Follow G1 Therapeutics as it advances trilaciclib in Phase 3 PRESERVE 2 trial for metastatic triple-negative breast cancer. Updates on trial progress, interim analysis, and potential FDA filing in... Via Benzinga Exposures Product Safety Why IPG Photonics Shares Are Trading Lower By Around 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session February 13, 2024 Shares of IPG Photonics Corporation (NASDAQ: IPGP) fell sharply during Tuesday’s session after the company reported mixed fourth-quarter financial results and issued soft first-quarter guidance. Via Benzinga 12 Health Care Stocks Moving In Tuesday's Intraday Session February 13, 2024 Via Benzinga Evercore ISI Is Warming Up to NextEra Energy (NEE) Stock February 13, 2024 NextEra Energy stock is on the move Tuesday after Evercore ISI initiated coverage of NEE shares with a bull rating and price target. Via InvestorPlace < Previous 1 2 3 4 5 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.